Valuation Abbott Laboratories

Stocks

Market Closed - NYSE 07:03:40 17/10/26 am AEDT			5-day change	1st Jan Change
104.89 ^USD	+0.20%		+6.50%	-16.28%

14/10	Johnson & Johnson's Upgraded Full-Year Outlook Misses Wall Street Views; Stock Declines	MT
09/10	Trump Disclosed 517 Securities Transactions in August, Including Up to $25 Million Meta Purchase	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	241,365	191,427	191,088	196,184	217,859	181,137	-	-
Change	-	-20.69%	-0.18%	2.67%	11.05%	-16.86%	-	-
Enterprise Value (EV) ¹	249,166	198,318	198,871	202,693	222,266	205,076	202,094	198,403
Change	-	-20.41%	0.28%	1.92%	9.66%	-7.73%	-1.45%	-1.83%
P/E	35.7x	28.1x	33.8x	14.8x	33.7x	30.9x	24x	21x
PBR	6.93x	5.2x	4.94x	4.11x	4.18x	3.79x	3.63x	3.44x
PEG	-	-36.9x	-2x	0x	-0.7x	-3.48x	0.8x	1.5x
Capitalization / Revenue	5.6x	4.39x	4.76x	4.68x	4.91x	3.61x	3.32x	3.11x
EV / Revenue	5.78x	4.54x	4.96x	4.83x	5.01x	4.09x	3.71x	3.41x
EV / EBITDA	19.4x	15.9x	19.5x	19.1x	18.9x	15.8x	14x	12.5x
EV / EBIT	22x	17.7x	22.3x	21.8x	21.6x	17.5x	15.5x	13.9x
EV / FCF	28.8x	25.4x	39.3x	31.9x	30.1x	27.2x	22.7x	20.7x
FCF Yield	3.47%	3.94%	2.54%	3.13%	3.33%	3.68%	4.41%	4.83%
Dividend per Share ²	1.82	1.92	2.08	2.24	2.4	2.57	2.741	2.898
Rate of return	1.29%	1.75%	1.89%	1.98%	1.92%	2.45%	2.61%	2.76%
EPS ²	3.94	3.91	3.26	7.64	3.72	3.389	4.374	4.986
Distribution rate	46.2%	49.1%	63.8%	29.3%	64.5%	75.8%	62.7%	58.1%
Net sales ¹	43,075	43,653	40,109	41,950	44,328	50,198	54,525	58,249
EBITDA ¹	12,815	12,485	10,188	10,635	11,735	12,985	14,467	15,891
EBIT ¹	11,324	11,231	8,911	9,295	10,301	11,721	13,019	14,316
Net income ¹	7,071	6,933	5,723	13,402	6,524	6,162	7,843	8,710
Net Debt ¹	7,801	6,891	7,783	6,509	4,407	23,939	20,957	17,267
Reference price ²	140.74	109.79	110.07	113.11	125.29	104.89	104.89	104.89
Nbr of stocks (in thousands)	1,714,968	1,743,574	1,736,059	1,734,455	1,738,834	1,730,383	-	-
Announcement Date	26/1/22	25/1/23	24/1/24	22/1/25	22/1/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ABBOTT LABORATORIES	30.89x	4.09x	15.79x	2.46%	181B
MEDTRONIC PLC	20.43x	3.54x	12.67x	2.95%	117B
STRYKER CORPORATION	22.83x	4.47x	15.61x	1.23%	112B
ESSILORLUXOTTICA	26.34x	2.59x	10.38x	2.72%	76.56B
CENCORA, INC.	18.73x	0.22x	13.57x	0.7%	65.15B
HOYA CORPORATION	30.39x	7.54x	19.43x	1.32%	52.79B
BECTON, DICKINSON AND COMPANY	37.34x	3.56x	12.2x	2.02%	52.78B
IDEXX LABORATORIES, INC.	37.06x	9.21x	25.79x	-.--%	43.11B
MEDLINE INC.	49.13x	1.34x	12.46x	0.2%	32.08B
DEXCOM, INC.	35.24x	6.18x	19.41x	-.--%	33.1B
Average	30.84x	4.27x	15.73x	1.36%	76.6B
Weighted average by Cap.	28.33x	4.05x	15.14x	1.78%